Research has also focused on targeting CMG2 or TEM8 for cancer therapy62, especially using anti-TEM8 antibodies63,64, CMG2 vWA domain fragments65, or anthrax toxin itself66 for slowing cancer progression. The gene discussed is ANTXR1; the disease is cancer.